The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
INTRODUCTION
•Hereditary transthyretin amyloidosis (hATTR/ATTRv) is a progressive and fatal disease caused by mutations in the transthyretin (TTR) gene
•These mutations destabilize protein folding, resulting in amyloid deposits and causing multisystem dysfunction such as cardiomyopathy (CM), whose etiology may be attributed to traditional causes of cardiovascular diseases
•Genetic testing is required for determining a diagnosis of hATTR/ATTRvwith CM
OBJECTIVE
•To describe the prevalence and characteristics of patients with TTRmutations versus patients with mutations associated with other inherited cardiovascular conditions
BACKGROUND •Hereditary transthyretin amyloidosis (hATTR or ATTRv[variant]) is a progressive and fatal disease caused by mutations in the transthyretin (TTR) gene…
A secondary analysis of psychosocial health outcomes reported by patients with cardiovascular disease during the COVID-19 social distancing guidelines. Findings include significant difference in social isolation, anxiety, depression and cognitive function…
The study reports patient satisfaction with virtual heart failure visits during the initial 30 day surge of the COVID 19 pandemic, and compares their satisfaction with in-office visits over the preceding 3 months…
BACKGROUND/INTRODUCTION • Hereditary transthyretin amyloidosis (hATTR or ATTRv [variant]) is a progressive and fatal disease often associated with infiltrative cardiac involvement • Cardiac involvement in ATTRv is associated with poor survival • Patients often have long-standing cardiac symptoms pr…